Period Problems: Sleepless Nights Before Menstruation

Sleep issues are among the most common symptoms attributed to premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Research shows that 30% of people experience disturbed sleep during their periods, with 23% struggling to get a full eight hours in the week leading up to their period. While the exact cause of this is still unknown, there are several theories as to why this happens. One theory is that the drop in progesterone levels during the luteal phase of the menstrual cycle affects sleep quality. Another theory is that the drop in estrogen levels during the luteal phase could cause sleep problems. A third theory is that people with PMS or PMDD have decreased melatonin secretion, which is the hormone that helps facilitate sleep.

Hormonal changes, such as a drop in progesterone, can cause insomnia before a period

Sleep disturbances are common in the days leading up to a person's period. Research shows that people are more likely to experience insomnia before their period, with twice as many people experiencing insomnia in the week before their period.

During the luteal phase of the menstrual cycle, progesterone is the dominant hormone. This phase lasts about two weeks from ovulation. If a woman does not become pregnant, progesterone levels will dip, triggering the beginning of another menstrual cycle. This dip in progesterone during the period is what may cause difficulty sleeping.

Progesterone levels are highest in the luteal phase (the second half) of the menstrual cycle. If a woman does not ovulate, her body will not produce progesterone. Even if she does ovulate, a weak rise in progesterone can cause insomnia a few days before her period. This is often the case for women with polycystic ovary syndrome (PCOS), who may experience irregular or absent ovulation.

Additionally, perimenopause is a time of hormonal transition when progesterone levels typically decline first. During this time, there may be months when a woman does not ovulate, leading to more frequent insomnia.

Some women who ovulate regularly may still suffer from a progesterone deficiency known as a luteal phase defect. In this case, the body may produce weak amounts of progesterone after ovulation, or progesterone levels may drop too quickly. A healthy luteal phase should last around 12 to 16 days. Women with shorter luteal phases often suffer from symptoms of progesterone deficiency, including insomnia.

Low levels of progesterone are usually the root cause of sleep difficulties before a period. However, it is important to note that other factors, such as premenstrual syndrome (PMS) and changes in body temperature, may also contribute to insomnia during this time.

Estrogen affects the sleep-wake cycle, helping to keep body temperature low at night

Sleep is important for keeping hormones balanced. Many hormones in the body are influenced by sleep or the circadian rhythm (also known as the sleep-wake cycle). The sleep-wake cycle is controlled by the suprachiasmatic nucleus, which is regulated by the hypothalamus.

Estrogen is one of the hormones that are influenced by the sleep-wake cycle. It is the main female sex hormone and helps control the monthly menstruation cycle. Estrogen has a regulating effect on body temperature. During the night, estrogen plays a role in keeping the body's core temperature low. This is because estrogen is a hormone that regulates the lowest body temperature during the night. When estrogen levels are low, this time shift forwards, and the depth of the temperature drop changes.

The sleep-wake cycle is also influenced by hormones. Immediately before menstruation, a woman's progesterone levels dip dramatically, which is why some women find it difficult to get quality sleep in the days leading up to their period. After menstruation, progesterone levels slowly rise again, which can make it easier to sleep.

The impact of hormones on the sleep-wake cycle is particularly notable during menopause. At this time, women experience a drop in estrogen levels, which can cause night sweats and hot flashes that wake the brain during sleep. Estrogen replacement therapy can help improve sleep quality during menopause.

Melatonin, which regulates the sleep-wake cycle, is decreased in women with PMDD

Sleep disturbances are common in the days leading up to a person's period. Research shows that people experience more sleep disruptions before their period, with many reporting that they feel more fatigued during the day.

Women with premenstrual dysphoric disorder (PMDD) have the worst luck with sleep as they near their period. PMDD is a mood disorder that affects around 3-8% of women, causing symptoms such as depression, tension, and irritability. Notably, up to 70% of women with PMDD experience insomnia symptoms before their period.

While the exact cause of sleep problems during this time is not fully understood, it is believed that hormonal changes that affect body temperature and melatonin production play a role. Specifically, studies have found that women with PMDD make less melatonin, a hormone that helps regulate the sleep-wake cycle.

One study found that compared to healthy controls, women with PMDD had significantly decreased melatonin secretion levels during the nighttime hours. This reduction in melatonin may be due to an abnormal MT1/MT2 ratio, which refers to the ratio of melatonin receptors in the body. Additionally, PMDD women had a further reduction of melatonin levels during their symptomatic luteal phase compared to the asymptomatic follicular phase.

These findings highlight the importance of considering melatonin and circadian rhythms in the treatment of PMDD. By targeting the melatonin system specifically, or more broadly, the circadian system, clinicians may be able to better manage symptoms, including insomnia, in women with PMDD.

Anxiety, depression and mood swings associated with PMS and PMDD can affect sleep quality

Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are associated with anxiety, depression, and mood swings, which can affect sleep quality.

PMS is a condition that affects up to 75% of menstruating women, causing a wide variety of signs and symptoms, including mood swings, tender breasts, food cravings, fatigue, irritability, and depression. These symptoms typically recur in a predictable pattern before the period and disappear within four days of the start of the menstrual period. However, a small number of women with PMS experience disabling symptoms every month, which is classified as PMDD.

PMDD is a more severe form of PMS, affecting about 5% to 10% of women or people assigned female at birth. It involves physical and behavioral symptoms that show up in a recurring pattern, usually during the second half of the menstrual cycle. In addition to PMS symptoms like bloating, breast tenderness, and headaches, PMDD causes severe anxiety, depression, and mood swings. These symptoms can be debilitating and significantly impact one's quality of life.

The exact causes of PMDD are unknown, but it is believed to be related to hormonal changes and neurotransmitters in the brain. Studies have shown that the menstrual cycle influences neurotransmitters like serotonin, which regulates mood, hunger, and sleep. Insufficient serotonin levels may contribute to premenstrual depression, fatigue, food cravings, and sleep problems.

The impact of anxiety, depression, and mood swings associated with PMS and PMDD on sleep quality is significant. Research shows that sleep quality is worse before a person's period, with increased difficulty falling asleep and more frequent awakenings. This may be due to menstrual symptoms, such as cramps and headaches, or hormonal changes affecting body temperature and melatonin production.

Additionally, the emotional and behavioral symptoms of PMS and PMDD can easily disrupt sleep. Feeling depressed, angry, anxious, or irritable can make it challenging to get a good night's rest. The worst time for sleep and mood, even in those without major PMS, is during the 4-5 days before and the first two days of the period.

Treating the underlying anxiety, depression, and mood swings associated with PMS and PMDD can help improve sleep quality. Lifestyle changes, such as reducing salt, sugar, caffeine, and alcohol intake, addressing stress, and practicing relaxation techniques, can be beneficial. In more severe cases, hormonal contraceptives or antidepressants may be prescribed to manage both mood and sleep issues.

Polycystic ovary syndrome (PCOS) can cause sleep apnea, which may worsen sleep

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting pre-menopausal women, characterised by hyperandrogenism, oligoanovulation, obesity, and insulin resistance. PCOS is the most common cause of female infertility, affecting 5-8% of reproductive-aged women in the US. Women with PCOS are at an increased risk of developing metabolic and cardiovascular disorders, including type 2 diabetes, hypertension, and dyslipidemia.

Recent studies have found an unexpectedly high prevalence of obstructive sleep apnea (OSA) in women with PCOS. Obstructive sleep apnea is a sleep disorder that causes repeated interruptions in breathing during sleep due to a blocked airway, reducing the amount of air that reaches the lungs. This condition can have severe health consequences if left untreated, including an increased risk of type 2 diabetes.

The exact causal mechanisms between PCOS and OSA are not yet fully understood. However, alterations in sex steroids, such as high androgen and low estrogen levels, as well as increased visceral adiposity, may contribute to the development of OSA in women with PCOS. Additionally, the underproduction of ovarian estrogen in women with PCOS can result in subnormal estrogen levels, which have also been associated with poor sleep quality.

Studies have found that women with PCOS are more likely to experience poor sleep quality and chronic daytime sleepiness, which may be indicative of OSA. Untreated sleep apnea can further worsen other PCOS symptoms and increase the risk of developing associated health problems such as type 2 diabetes, obesity, and cardiovascular disease. Therefore, it is crucial for clinicians managing PCOS patients to be aware of the high prevalence of OSA in this population and to systematically evaluate these women for sleep disturbances.

Frequently asked questions